Genes | Official gene name | Cofactors | Tissue enrichmenta | Chr | PC | SNPs |
---|---|---|---|---|---|---|
CACNA1A | Calcium voltage-gated channel subunit alpha1 A | Ca | Tissue enhanced: cerebral cortex; stomach | 19 | PC3 | rs7254771 (0.03) |
CACNB4 | Calcium voltage-gated channel auxiliary subunit beta 4 | Ca | Tissue enhanced: cerebral cortex | 2 | PC5 | rs16830593 (0.007); rs11902858 (0.02) |
HPX | Hemopexin | Fe | Tissue enriched: liver | 11 | PC5 | rs16913549 (0.01) |
KCNB2 | Potassium voltage-gated channel subfamily B member 2 | K | Tissue enhanced: cerebral cortex; spleen | 8 | PC5 | rs7833062 (0.04); rs6996335 (0.02) |
KCNH5 | Potassium voltage-gated channel subfamily H member 5 | K | Tissue enhanced: adrenal gland; cerebral cortex | 14 | PC5 | rs8019319 (0.007) |
KCNH7 | Potassium voltage-gated channel subfamily H member 7 | K | Tissue enriched: cerebral cortex | 2 | PC3; PC5 | rs6753132 (0.05); rs6708255 (0.007); rs7588788 (0.07) |
KCNK13 | Potassium two pore domain channel subfamily K member 13 | K | Tissue enhanced: testis | 14 | PC3 | rs3861656 (0.025); rs4462529 (0.025); rs17223880 (0.025) |
LRP2 | LDL receptor related protein 2 | D3 | Group enriched: kidney; placenta; thyroid gland | 2 | PC5 | rs16856593 (0.004) |
RYR2 | Ryanodine receptor 2 | Ca | Tissue enriched: heart muscle | 1 | PC5 | rs12087761 (0.011) |
SLC11A2 | Solute carrier family 11 member 2 | Co | Expressed in all | 12 | PC5 | rs12312876 (2.70E-08) |
SLC24A3 | Solute carrier family 24 member 3 | K,Ca | Mixed | 20 | PC5 | rs10485588 (0.04); rs16980447 (0.03); rs6112335 (0.02); rs6035421 (0.02) |
SLC25A26 | Solute carrier family 25 member 26 | SAM | Expressed in all | 3 | PC3 | rs17044224 (0.03); rs1471476 (0.03); |
SLCO1A2 | Solute carrier organic anion transporter family member 1A2 | GSH | Group enriched: cerebral cortex; liver; lung; salivary gland | 12 | PC5 | rs2199685 (0.03) |
TRPM4 | Transient receptor potential cation channel subfamily M member 4 | Ca | Mixed | 19 | PC5 | rs8104571 (0.0008) |